Cargando…
Group B streptococcal infections in infants in Iceland: clinical and microbiological factors
INTRODUCTION: Group B streptococcus (GBS) is a leading cause of invasive neonatal infections. These have been divided into early-onset disease (EOD; <7 days) and late-onset disease (LOD; 7–89 days), with different GBS clonal complexes (CCs) associated with different disease presentations. HYPOTHE...
Autores principales: | Baeringsdottir, Birta, Erlendsdottir, Helga, Bjornsdottir, Erla Soffia, Martins, Elisabete R., Ramirez, Mário, Haraldsson, Asgeir, Thorkelsson, Thordur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Microbiology Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8697508/ https://www.ncbi.nlm.nih.gov/pubmed/34554080 http://dx.doi.org/10.1099/jmm.0.001426 |
Ejemplares similares
-
The Effect of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine on H. influenzae in Healthy Carriers and Middle Ear Infections in Iceland
por: Sveinsdóttir, Hildigunnur, et al.
Publicado: (2019) -
Reduction of antimicrobial resistant pneumococci seven years after introduction of pneumococcal vaccine in Iceland
por: Hjálmarsdóttir, Martha Á., et al.
Publicado: (2020) -
Comparison of Serotype Prevalence of Pneumococci Isolated from Middle Ear, Lower Respiratory Tract and Invasive Disease Prior to Vaccination in Iceland
por: Hjálmarsdóttir, Martha Á., et al.
Publicado: (2017) -
Vaccination of Icelandic Children with the 10-Valent Pneumococcal Vaccine Leads to a Significant Herd Effect among Adults in Iceland
por: Quirk, Sigríður J., et al.
Publicado: (2019) -
The impact and cost-effectiveness of introducing the 10-valent pneumococcal conjugate vaccine into the paediatric immunisation programme in Iceland—A population-based time series analysis
por: Eythorsson, Elias, et al.
Publicado: (2021)